Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108)

Tomi Akinyemiju, Justin X. Moore, Daniel Tefera Dibaba, Maria Pisu, Michael Goodman, Virginia J. Howard, Monika Safford, Susan C. Gilchrist, Mary Cushman, Leann Long, Suzanne E. Judd

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: The third author in the listing, along with a new affiliation, has been added as follows: Daniel Tefera Dibaba3 3Tennessee Clinical and Translational Science Institute, University of Tennessee Health Science Center, Memphis, TN, USA.

Original languageEnglish (US)
Number of pages1
JournalOncotarget
Volume11
Issue number7
StatePublished - Feb 18 2020
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108)'. Together they form a unique fingerprint.

  • Cite this

    Akinyemiju, T., Moore, J. X., Dibaba, D. T., Pisu, M., Goodman, M., Howard, V. J., Safford, M., Gilchrist, S. C., Cushman, M., Long, L., & Judd, S. E. (2020). Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108). Oncotarget, 11(7).